About Peripheral Vascular Stents
Peripheral vascular stents are most commonly used in treating conditions called as PVDs. It is crampy leg pain that occurs during walking and exercise. It occurs in individuals aged 65 and above and is the result of atherosclerosis (hardening of the arteries), which occurs due to scar tissue and cholesterol build up, forming a substance called plaque inside the arteries.
Technavio’s analysts forecast the global peripheral vascular stents market to grow at a CAGR of 7.96% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global peripheral vascular stents market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Peripheral Vascular Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Boston Scientific
• Abbott
• Medtronic
• Cook
• C. R. Bard
• BIOTRONIK
• Cordis (a Cardinal Health company)
Other prominent vendors
• 480 Biomedical
• Alvimedica
• B. Braun Melsungen
• Balton
• Bentley
• Biosensors International Group
• ENDOCOR
• eucatech
• InSitu Technologies
• InspireMD
• iVascular
• KYOTO MEDICAL PLANNING
• Meril Life Sciences
• optimed
• PanMed US
• RONTIS
• Terumo Medical
• Veryan Medical
• W. L. Gore & Associates
Market driver
• Ubiquity of PAD
• For a full, detailed list, view our report
Market challenge
• Risks and complications associated with peripheral vascular stents
• For a full, detailed list, view our report
Market trend
• Technology caters the pace for advances in stenting
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research methodology
PART 04: Introduction
• Peripheral vascular stents
PART 05: Market landscape
• Market overview
PART 06: Five forces analysis
PART 07: Market segmentation by product
• Global self-expanding peripheral vascular stents market
• Global balloon-expanding peripheral vascular stents market
• Global drug-eluting peripheral vascular stents market
PART 08: Market segmentation by end-user
• Hospitals
• ASCs
• Cath labs
PART 09: Geographical segmentation
• Peripheral vascular stents market in Americas
• Peripheral vascular stents market in EMEA
• Peripheral vascular stents market in APAC
PART 10: Decision framework
PART 11: Drivers and challenges
• Market drivers
• Market challenges
PART 12: Market trends
• Technology caters the pace for advances in stenting
• Emergence of bioabsorbable stents
• New product launches and ongoing clinical trials
PART 13: Vendor landscape
• Competitive scenario
PART 14: Key vendor analysis
• Boston Scientific
• Abbott
• Medtronic
• Cook
• C. R. Bard
• BIOTRONIK
• Cordis (a Cardinal Health company)
• Other prominent vendors
PART 15: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Share of stents usage in different peripheral arteries 2016 (%)
Exhibit 02: Global peripheral vascular stents market 2016-2021 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global peripheral vascular stents market by product
Exhibit 05: Global peripheral vascular stents market by product 2016 and 2021 (%)
Exhibit 06: Global peripheral vascular stents market analysis by product
Exhibit 07: Global peripheral vascular stents market by product 2016 and 2021 ($ millions)
Exhibit 08: Global peripheral vascular stents market by product 2016-2021 ($ millions)
Exhibit 09: Global peripheral vascular stents market by product 2016-2021 (%)
Exhibit 10: Global self-expanding peripheral vascular stents market 2016-2021 ($ millions)
Exhibit 11: Global balloon-expanding peripheral vascular stents market 2016-2021 ($ millions)
Exhibit 12: Global drug-eluting peripheral vascular stents market 2016-2021 ($ millions)
Exhibit 13: Global peripheral vascular stents market by end-users 2016
Exhibit 14: Global peripheral vascular stents market by geography 2016 (%)
Exhibit 15: Global peripheral vascular stents market by geography 2021 (%)
Exhibit 16: Global peripheral vascular stents market by geography 2016 and 2021 (%)
Exhibit 17: Global peripheral vascular stents market by geography 2016 and 2021 ($ millions)
Exhibit 18: Global peripheral vascular stents market analysis by geography 2016
Exhibit 19: Peripheral vascular stents market in Americas 2016-2021 ($ millions)
Exhibit 20: Peripheral vascular stents market in EMEA 2016-2021 ($ millions)
Exhibit 21: Peripheral vascular stents market in APAC 2016-2021 ($ millions)
Exhibit 22: Global peripheral vascular stents market by geography 2016-2021 ($ millions)
Exhibit 23: Global peripheral vascular stents market by geography 2016-2021 (%)
Exhibit 24: New product launches 2015-2016
Exhibit 25: Various active ongoing clinical studies on peripheral vascular stents
Exhibit 26: Competitive structure analysis of global peripheral vascular stents market 2016
Exhibit 27: Market share of vendors in global peripheral vascular stents market 2016
Exhibit 28: Leading vendors ranking in global peripheral vascular stents market 2016
Exhibit 29: Boston Scientific: Key highlights
Exhibit 30: Boston Scientific: Strength assessment
Exhibit 31: Boston Scientific: Strategy assessment
Exhibit 32: Boston Scientific: Opportunity assessment
Exhibit 33: Abbott: Key highlights
Exhibit 34: Abbott: Strength assessment
Exhibit 35: Abbott: Strategy assessment
Exhibit 36: Abbott: Opportunity assessment
Exhibit 37: Medtronic: Key highlights
Exhibit 38: Medtronic: Strength assessment
Exhibit 39: Medtronic: Strategy assessment
Exhibit 40: Medtronic: Opportunity assessment
Exhibit 41: Cook: Key highlights
Exhibit 42: Cook: Strength assessment
Exhibit 43: Cook: Strategy assessment
Exhibit 44: Cook: Opportunity assessment
Exhibit 45: C. R. Bard: Key highlights
Exhibit 46: C. R. Bard: Strength assessment
Exhibit 47: C. R. Bard: Strategy assessment
Exhibit 48: C. R. Bard: Opportunity assessment
Exhibit 49: BIOTRONIK: Key highlights
Exhibit 50: BIOTRONIK: Strength assessment
Exhibit 51: BIOTRONIK: Strategy assessment
Exhibit 52: BIOTRONIK: Opportunity assessment
Exhibit 53: Cordis: Key highlights
Exhibit 54: Cordis: Strength assessment
Exhibit 55: Cordis: Strategy assessment
Exhibit 56: Cordis: Opportunity assessment
